Loading...
XASE
AMS
Market cap15mUSD
Jun 13, Last price  
2.37USD
1D
0.41%
1Q
-13.88%
Jan 2017
-27.76%
Name

American Shared Hospital Services

Chart & Performance

D1W1MN
P/E
6.99
P/S
0.54
EPS
0.34
Div Yield, %
—
Shrs. gr., 5y
2.48%
Rev. gr., 5y
6.58%
Revenues
28m
+32.90%
18,231,00020,385,00022,622,00019,099,00016,768,00016,675,00022,221,00017,048,00017,584,00015,417,00016,548,00018,700,00019,556,00019,714,00020,605,00017,837,00017,628,00019,746,00021,325,00028,340,000
Net income
2m
+258.36%
1,767,0001,656,000951,000477,000-188,00057,000506,00038,000-312,000-952,000-1,522,000930,0001,923,0001,023,0001,430,000-7,716,000678,0001,328,000610,0002,186,000
CFO
167m
+2,820.60%
8,480,0009,164,0008,484,0008,947,0007,704,0007,184,0006,823,0006,871,0008,076,0006,773,0008,548,0008,378,0007,853,0008,062,0008,047,0009,745,0006,267,0007,235,0005,718,000167,000,000
Dividend
Jun 28, 20070.0475 USD/sh
Earnings
Aug 12, 2025

Profile

American Shared Hospital Services leases radiosurgery and radiation therapy equipment to health care providers. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. As of December 31, 2021, it had 115 operating Gamma Knife units located in the United States, as well as two in South America in Lima, Peru and Guayaquil, Ecuador. The company also operates one PBRT system. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.
URL
https://ashs.com/
IPO date
Jul 04, 1984
Employees
28
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
28,340
32.90%
21,325
8.00%
19,746
12.01%
Cost of revenue
19,155
6,908
11,364
Unusual Expense (Income)
NOPBT
9,185
14,417
8,382
NOPBT Margin
32.41%
67.61%
42.45%
Operating Taxes
(295)
431
963
Tax Rate
2.99%
11.49%
NOPAT
9,480
13,986
7,419
Net income
2,186
258.36%
610
-54.07%
1,328
95.87%
Dividends
Dividend yield
Proceeds from repurchase of equity
5
BB yield
-0.03%
Debt
Debt current
4,641
2,051
Long-term debt
1,501,726
11,098
12,615
Deferred revenue
70
Other long-term liabilities
17,341,000
63
4,000
Net debt
(9,523,274)
2,049
2,213
Cash flow
Cash from operating activities
167,000
5,718
7,235
CAPEX
(7,938,000)
(6,273)
(388)
Cash from investing activities
(7,105,000)
(6,273)
(388)
Cash from financing activities
4,405,000
1,910
(2,657)
FCF
(36,929,517)
11,932
11,780
Balance
Cash
11,025,000
13,690
12,453
Long term investments
Excess cash
11,023,583
12,624
11,466
Stockholders' equity
21,422,000
18,047
17,782
Invested Capital
37,844,417
30,626
28,289
ROIC
0.05%
47.48%
21.60%
ROCE
0.02%
33.33%
20.66%
EV
Common stock shares outstanding
6,703
6,393
6,303
Price
3.19
34.07%
2.38
-18.79%
2.93
23.63%
Market cap
21,383
40.57%
15,212
-17.63%
18,468
28.61%
EV
(4,657,891)
20,916
24,681
EBITDA
15,359
19,582
13,165
EV/EBITDA
1.07
1.87
Interest
1,499
1,112
806
Interest/NOPBT
16.32%
7.71%
9.62%